Wells Fargo & Company Pacira Bio Sciences, Inc. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PCRX
# of Institutions
273Shares Held
48.6MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$140 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$89 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$86.8 Million0.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$36.2 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$33.3 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $802M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...